Biotechnology
The Biotechnology industry has a total of 644 stocks, with a combined market cap of $810.58 billion and total revenue of $98.24 billion.
Market Cap
810.58B
Revenue
98.24B
Profits
-45.24B
PE Ratio
n/a
Profit Margin
-46.05%
Dividend Yield
0.05%
644 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.35B | 0.43% | 521,703 | 11.10B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 54.73B | -0.58% | 351,144 | 14.09B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.75B | 0.62% | 418,052 | 2.35B |
| 4 | ARGX | argenx SE | 34.29B | 0.27% | 340,147 | 2.64B |
| 5 | ONC | BeOne Medicines Ltd. | 28.49B | -5.66% | 225,099 | 4.18B |
| 6 | BNTX | BioNTech SE | 26.18B | 0.16% | 217,783 | 2.97B |
| 7 | RPRX | Royalty Pharma plc | 19.91B | 0.43% | 936,154 | 2.26B |
| 8 | INSM | Insmed Incorporated | 19.01B | -1.61% | 2,522,052 | 381.03M |
| 9 | SMMT | Summit Therapeutics Inc. | 15.41B | -2.67% | 819,345 | - |
| 10 | INCY | Incyte Corporation | 13.24B | -3.40% | 661,510 | 4.41B |
| 11 | GMAB | Genmab A/S | 12.67B | -1.01% | 426,061 | 3.23B |
| 12 | EXEL | Exelixis, Inc. | 11.86B | 0.91% | 947,173 | 2.30B |
| 13 | BMRN | BioMarin Pharmaceutical Inc. | 10.51B | 1.26% | 1,079,988 | 2.95B |
| 14 | MRNA | Moderna, Inc. | 10.43B | -2.03% | 3,542,973 | 3.18B |
| 15 | ASND | Ascendis Pharma A/S | 10.38B | -0.55% | 120,020 | 398.51M |
| 16 | VRNA | Verona Pharma plc | 8.53B | -0.85% | 595,922 | 118.54M |
| 17 | BBIO | BridgeBio Pharma, Inc. | 8.45B | -1.37% | 2,101,601 | 127.42M |
| 18 | BPMC | Blueprint Medicines Corporation | 8.30B | - | 1,677,009 | 562.12M |
| 19 | TECH | Bio-Techne Corporation | 8.05B | -2.78% | 1,052,585 | 1.21B |
| 20 | CORT | Corcept Therapeutics Incorporated | 7.87B | -0.13% | 415,368 | 685.45M |
| 21 | ROIV | Roivant Sciences Ltd. | 7.66B | -2.84% | 4,912,707 | 29.05M |
| 22 | CAI | Caris Life Sciences, Inc. | 7.37B | -0.90% | 353,763 | 452.50M |
| 23 | RVMD | Revolution Medicines, Inc. | 6.94B | -0.64% | 1,566,167 | - |
| 24 | MDGL | Madrigal Pharmaceuticals, Inc. | 6.67B | 0.23% | 256,541 | 317.38M |
| 25 | LEGN | Legend Biotech Corporation | 6.50B | 5.35% | 1,047,558 | 728.30M |
| 26 | JAZZ | Jazz Pharmaceuticals plc | 6.49B | -0.29% | 316,536 | 4.06B |
| 27 | HALO | Halozyme Therapeutics, Inc. | 6.47B | 0.02% | 1,047,050 | 1.08B |
| 28 | IONS | Ionis Pharmaceuticals, Inc. | 6.33B | -0.08% | 1,159,345 | 717.25M |
| 29 | NUVL | Nuvalent, Inc. | 5.81B | 2.33% | 546,924 | - |
| 30 | TLX | Telix Pharmaceuticals Limited | 5.41B | -1.83% | 13,106 | 484.69M |
| 31 | TGTX | TG Therapeutics, Inc. | 5.36B | -3.24% | 676,577 | 386.39M |
| 32 | AXSM | Axsome Therapeutics, Inc. | 5.17B | 2.03% | 294,304 | 432.16M |
| 33 | AKRO | Akero Therapeutics, Inc. | 4.44B | -0.99% | 795,690 | - |
| 34 | ADMA | ADMA Biologics, Inc. | 4.34B | -1.25% | 2,121,490 | 459.38M |
| 35 | CRSP | CRISPR Therapeutics AG | 4.30B | 0.43% | 1,339,888 | 37.68M |
| 36 | PCVX | Vaxcyte, Inc. | 4.28B | 0.91% | 759,321 | - |
| 37 | SLNO | Soleno Therapeutics, Inc. | 4.24B | 0.07% | 501,901 | - |
| 38 | KRYS | Krystal Biotech, Inc. | 4.02B | -2.50% | 111,656 | 333.45M |
| 39 | CYTK | Cytokinetics, Incorporated | 3.99B | -1.56% | 731,357 | 19.22M |
| 40 | MRUS | Merus N.V. | 3.96B | -0.08% | 142,384 | 54.73M |
| 41 | PTCT | PTC Therapeutics, Inc. | 3.94B | 0.42% | 187,159 | 1.77B |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 3.89B | -0.43% | 205,385 | 136.86M |
| 43 | ZLAB | Zai Lab Limited | 3.86B | -3.63% | 523,777 | 418.33M |
| 44 | ACAD | ACADIA Pharmaceuticals Inc. | 3.65B | -1.80% | 546,377 | 996.28M |
| 45 | ACLX | Arcellx, Inc. | 3.58B | 0.36% | 331,940 | 76.81M |
| 46 | RNA | Avidity Biosciences, Inc. | 3.54B | -1.54% | 308,149 | 8.93M |
| 47 | SWTX | SpringWorks Therapeutics, Inc. | 3.54B | -0.01% | 4,507,655 | 219.67M |
| 48 | RARE | Ultragenyx Pharmaceutical Inc. | 3.44B | -1.91% | 1,489,687 | 590.69M |
| 49 | PTGX | Protagonist Therapeutics, Inc. | 3.43B | 0.14% | 272,518 | 207.80M |
| 50 | SRRK | Scholar Rock Holding Corporation | 3.39B | 0.78% | 473,030 | - |
| 51 | AAPG | Ascentage Pharma Group International | 3.38B | -4.39% | 5,979 | 134.35M |
| 52 | MLTX | MoonLake Immunotherapeutics | 3.04B | 1.18% | 310,510 | - |
| 53 | MTSR | Metsera, Inc. | 3.00B | -0.42% | 277,717 | - |
| 54 | VKTX | Viking Therapeutics, Inc. | 3.00B | -5.11% | 2,294,849 | - |
| 55 | KYMR | Kymera Therapeutics, Inc. | 2.89B | -3.06% | 2,183,063 | 58.89M |
| 56 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.83B | 0.87% | 308,899 | 760.00K |
| 57 | IMVT | Immunovant, Inc. | 2.71B | -3.11% | 313,676 | - |
| 58 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.67B | -0.18% | 521,462 | 534.65M |
| 59 | MIRM | Mirum Pharmaceuticals, Inc. | 2.52B | 0.51% | 130,218 | 379.25M |
| 60 | APGE | Apogee Therapeutics, Inc. | 2.51B | -1.96% | 314,604 | - |
| 61 | XENE | Xenon Pharmaceuticals Inc. | 2.48B | 0.22% | 776,270 | 7.50M |
| 62 | IBRX | ImmunityBio, Inc. | 2.38B | -3.41% | 3,139,238 | 31.22M |
| 63 | APLS | Apellis Pharmaceuticals, Inc. | 2.21B | -4.40% | 788,467 | 775.84M |
| 64 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.21B | -0.62% | 613,649 | 545.21M |
| 65 | LGND | Ligand Pharmaceuticals Incorporated | 2.19B | -1.73% | 69,694 | 181.49M |
| 66 | NAMS | NewAmsterdam Pharma Company N.V. | 2.10B | 1.46% | 547,653 | 47.14M |
| 67 | DNLI | Denali Therapeutics Inc. | 2.06B | -2.35% | 759,811 | - |
| 68 | VCEL | Vericel Corporation | 2.05B | -2.28% | 547,386 | 238.54M |
| 69 | RXRX | Recursion Pharmaceuticals, Inc. | 2.05B | -6.76% | 24,398,127 | 59.79M |
| 70 | CGON | CG Oncology, Inc. | 1.98B | -0.19% | 222,444 | 662.00K |
| 71 | BLTE | Belite Bio, Inc | 1.95B | 0.17% | 26,020 | - |
| 72 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | 0.09% | 181,142 | 37.04M |
| 73 | IRON | Disc Medicine, Inc. | 1.92B | 2.49% | 153,203 | - |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 1.90B | -2.69% | 300,222 | 7.00M |
| 75 | GLPG | Galapagos NV | 1.85B | -0.77% | 84,937 | 311.49M |
| 76 | SPRY | ARS Pharmaceuticals, Inc. | 1.82B | 2.71% | 1,838,170 | 97.12M |
| 77 | HRMY | Harmony Biosciences Holdings, Inc. | 1.82B | -0.69% | 130,321 | 744.85M |
| 78 | FOLD | Amicus Therapeutics, Inc. | 1.78B | 1.85% | 3,729,845 | 543.14M |
| 79 | ADPT | Adaptive Biotechnologies Corporation | 1.77B | -4.03% | 1,060,047 | 189.53M |
| 80 | CNTA | Centessa Pharmaceuticals plc | 1.71B | -1.69% | 272,230 | 15.00M |
| 81 | TARS | Tarsus Pharmaceuticals, Inc. | 1.70B | 0.52% | 133,653 | 233.67M |
| 82 | SRPT | Sarepta Therapeutics, Inc. | 1.67B | -1.33% | 2,699,202 | 2.23B |
| 83 | ARQT | Arcutis Biotherapeutics, Inc. | 1.67B | -2.92% | 1,194,454 | 212.82M |
| 84 | BEAM | Beam Therapeutics Inc. | 1.65B | -1.34% | 872,467 | 63.58M |
| 85 | IMCR | Immunocore Holdings plc | 1.57B | -2.59% | 91,739 | 333.58M |
| 86 | OCUL | Ocular Therapeutix, Inc. | 1.46B | -3.28% | 722,469 | 59.65M |
| 87 | VERA | Vera Therapeutics, Inc. | 1.45B | -2.06% | 1,081,226 | - |
| 88 | BHVN | Biohaven Ltd. | 1.45B | -3.87% | 1,149,461 | - |
| 89 | ETNB | 89bio, Inc. | 1.41B | -2.61% | 558,936 | - |
| 90 | MESO | Mesoblast Limited | 1.38B | 2.33% | 76,527 | 5.67M |
| 91 | EWTX | Edgewise Therapeutics, Inc. | 1.38B | 0.23% | 521,702 | - |
| 92 | JANX | Janux Therapeutics, Inc. | 1.37B | -1.72% | 151,561 | 9.34M |
| 93 | CLDX | Celldex Therapeutics, Inc. | 1.36B | -3.21% | 519,573 | 7.56M |
| 94 | TVTX | Travere Therapeutics, Inc. | 1.33B | -1.06% | 545,772 | 273.53M |
| 95 | INVA | Innoviva, Inc. | 1.24B | -2.80% | 316,732 | 369.84M |
| 96 | ELVN | Enliven Therapeutics, Inc. | 1.24B | -2.60% | 454,134 | - |
| 97 | GPCR | Structure Therapeutics Inc. | 1.21B | - | 195,029 | - |
| 98 | CVAC | CureVac N.V. | 1.21B | -0.56% | 517,872 | 566.04M |
| 99 | VRDN | Viridian Therapeutics, Inc. | 1.18B | -0.96% | 171,021 | 302.00K |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.17B | 0.46% | 868,334 | 247.30M |
| 101 | MNKD | MannKind Corporation | 1.13B | -1.06% | 1,342,152 | 297.60M |
| 102 | LQDA | Liquidia Corporation | 1.11B | 1.09% | 1,019,102 | 14.14M |
| 103 | DYN | Dyne Therapeutics, Inc. | 1.10B | -3.48% | 933,224 | - |
| 104 | NAGE | Niagen Bioscience, Inc. | 1.08B | -0.80% | 482,321 | 107.93M |
| 105 | ABCL | AbCellera Biologics Inc. | 1.06B | -4.81% | 4,738,705 | 23.11M |
| 106 | OCS | Oculis Holding AG | 1.05B | -0.69% | 6,377 | 847.33K |
| 107 | NVAX | Novavax, Inc. | 1.03B | -1.85% | 1,797,006 | 1.25B |
| 108 | WVE | Wave Life Sciences Ltd. | 1.02B | -5.41% | 328,909 | 104.94M |
| 109 | VERV | Verve Therapeutics, Inc. | 1.01B | 0.49% | 1,796,978 | 59.61M |
| 110 | CDTX | Cidara Therapeutics, Inc. | 999.77M | -0.52% | 1,024,338 | 302.00K |
| 111 | NTLA | Intellia Therapeutics, Inc. | 992.33M | -0.31% | 2,393,388 | 45.57M |
| 112 | GERN | Geron Corporation | 952.19M | -2.29% | 5,706,189 | 116.29M |
| 113 | PHVS | Pharvaris N.V. | 928.02M | -4.86% | 23,038 | - |
| 114 | SYRE | Spyre Therapeutics, Inc. | 926.43M | -4.18% | 132,162 | - |
| 115 | NRIX | Nurix Therapeutics, Inc. | 893.10M | -1.06% | 242,205 | 56.42M |
| 116 | MLYS | Mineralys Therapeutics, Inc. | 887.69M | -2.71% | 97,515 | - |
| 117 | ORIC | ORIC Pharmaceuticals, Inc. | 886.33M | -0.95% | 471,655 | - |
| 118 | ARDX | Ardelyx, Inc. | 882.85M | 0.14% | 1,139,614 | 361.71M |
| 119 | PRAX | Praxis Precision Medicines, Inc. | 877.39M | -2.19% | 51,787 | 8.12M |
| 120 | MDXG | MiMedx Group, Inc. | 873.66M | -0.42% | 120,365 | 352.38M |
| 121 | RCUS | Arcus Biosciences, Inc. | 868.26M | -3.53% | 378,608 | 141.00M |
| 122 | LENZ | LENZ Therapeutics, Inc. | 858.39M | 1.29% | 55,156 | - |
| 123 | ZYME | Zymeworks Inc. | 850.84M | -1.29% | 88,356 | 93.38M |
| 124 | CRMD | CorMedix Inc. | 831.53M | -18.05% | 6,359,318 | 82.55M |
| 125 | COGT | Cogent Biosciences, Inc. | 816.91M | -2.18% | 1,743,387 | - |
| 126 | AVXL | Anavex Life Sciences Corp. | 797.37M | -2.40% | 309,004 | - |
| 127 | SNDX | Syndax Pharmaceuticals, Inc. | 787.33M | -1.61% | 631,056 | 43.72M |
| 128 | AVBP | ArriVent BioPharma, Inc. | 782.10M | 0.22% | 63,375 | - |
| 129 | IMNM | Immunome, Inc. | 778.76M | 1.82% | 262,767 | 10.94M |
| 130 | GHRS | GH Research PLC | 771.63M | 0.32% | 35,802 | - |
| 131 | PHAR | Pharming Group N.V. | 750.10M | 0.55% | 5,625 | 320.71M |
| 132 | QURE | uniQure N.V. | 749.51M | -3.79% | 408,690 | 20.20M |
| 133 | XERS | Xeris Biopharma Holdings, Inc. | 736.71M | -2.95% | 539,513 | 222.55M |
| 134 | REPL | Replimune Group, Inc. | 716.91M | -1.69% | 321,794 | - |
| 135 | VIR | Vir Biotechnology, Inc. | 714.69M | -2.64% | 351,182 | 20.86M |
| 136 | IMTX | Immatics N.V. | 681.90M | 0.36% | 299,052 | 155.80M |
| 137 | PHAT | Phathom Pharmaceuticals, Inc. | 672.11M | 1.05% | 468,164 | 81.86M |
| 138 | NUVB | Nuvation Bio Inc. | 668.62M | -0.25% | 2,890,003 | 10.96M |
| 139 | TRVI | Trevi Therapeutics, Inc. | 663.64M | -1.59% | 365,966 | - |
| 140 | SION | Sionna Therapeutics, Inc. | 662.26M | 1.28% | 95,200 | - |
| 141 | GYRE | Gyre Therapeutics, Inc. | 661.79M | -1.08% | 82,612 | 100.64M |
| 142 | ANAB | AnaptysBio, Inc. | 661.65M | -3.68% | 143,572 | 111.87M |
| 143 | EYPT | EyePoint Pharmaceuticals, Inc. | 649.58M | -8.97% | 444,481 | 56.04M |
| 144 | DAWN | Day One Biopharmaceuticals, Inc. | 647.71M | -1.39% | 274,761 | 161.92M |
| 145 | STOK | Stoke Therapeutics, Inc. | 639.88M | -1.01% | 203,131 | 190.91M |
| 146 | SANA | Sana Biotechnology, Inc. | 636.07M | -1.74% | 2,072,181 | - |
| 147 | URGN | UroGen Pharma Ltd. | 617.84M | 2.21% | 1,150,622 | 91.87M |
| 148 | AUTL | Autolus Therapeutics plc | 614.79M | - | 675,357 | 9.01M |
| 149 | MRVI | Maravai LifeSciences Holdings, Inc. | 606.09M | - | 655,834 | 241.86M |
| 150 | ABUS | Arbutus Biopharma Corporation | 601.40M | -1.88% | 453,648 | 6.40M |
| 151 | UPB | Upstream Bio, Inc. | 586.35M | -0.37% | 140,772 | 2.30M |
| 152 | XNCR | Xencor, Inc. | 581.11M | -2.80% | 135,442 | 127.23M |
| 153 | SAGE | Sage Therapeutics, Inc. | 579.88M | -0.22% | 387,894 | 47.40M |
| 154 | KALV | KalVista Pharmaceuticals, Inc. | 578.69M | 1.22% | 660,940 | - |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 571.16M | -2.04% | 36,893 | 6.52M |
| 156 | RLAY | Relay Therapeutics, Inc. | 566.63M | -0.45% | 399,550 | 7.68M |
| 157 | IOVA | Iovance Biotherapeutics, Inc. | 561.01M | -3.45% | 6,551,194 | 212.68M |
| 158 | ARVN | Arvinas, Inc. | 559.11M | -1.79% | 605,633 | 426.90M |
| 159 | AMLX | Amylyx Pharmaceuticals, Inc. | 557.13M | -3.85% | 797,794 | -1.27M |
| 160 | DNA | Ginkgo Bioworks Holdings, Inc. | 556.64M | -1.04% | 984,290 | 237.42M |
| 161 | TBPH | Theravance Biopharma, Inc. | 552.51M | 2.98% | 223,616 | 65.27M |
| 162 | TNGX | Tango Therapeutics, Inc. | 551.73M | 3.46% | 1,210,594 | 40.99M |
| 163 | KROS | Keros Therapeutics, Inc. | 548.71M | - | 164,779 | 214.71M |
| 164 | MGTX | MeiraGTx Holdings plc | 536.68M | 0.12% | 149,602 | 34.51M |
| 165 | MAZE | Maze Therapeutics, Inc. | 535.20M | -4.08% | 53,225 | 167.50M |
| 166 | TSHA | Taysha Gene Therapies, Inc. | 508.75M | -1.66% | 726,769 | 7.22M |
| 167 | CAPR | Capricor Therapeutics, Inc. | 504.39M | 8.40% | 1,605,487 | 17.36M |
| 168 | BCYC | Bicycle Therapeutics plc | 502.09M | -0.41% | 112,438 | 25.72M |
| 169 | KURA | Kura Oncology, Inc. | 498.67M | 0.52% | 452,124 | 67.99M |
| 170 | MNMD | Mind Medicine (MindMed) Inc. | 497.90M | -2.23% | 368,698 | - |
| 171 | TYRA | Tyra Biosciences, Inc. | 492.43M | -5.80% | 193,218 | - |
| 172 | ZVRA | Zevra Therapeutics, Inc. | 491.57M | -3.12% | 238,389 | 40.59M |
| 173 | VALN | Valneva SE | 486.24M | 0.17% | 5,325 | 201.10M |
| 174 | BCAX | Bicara Therapeutics Inc. | 477.46M | -0.62% | 158,192 | - |
| 175 | CELC | Celcuity Inc. | 468.97M | 3.12% | 57,868 | - |
| 176 | SEPN | Septerna, Inc. | 466.75M | -3.63% | 211,145 | 977.00K |
| 177 | OPT | Opthea Limited | 466.57M | - | - | 208.86K |
| 178 | CGEM | Cullinan Therapeutics, Inc. | 460.02M | 0.58% | 89,929 | - |
| 179 | SVRA | Savara Inc. | 457.13M | -1.82% | 274,404 | - |
| 180 | FTRE | Fortrea Holdings Inc. | 454.51M | -3.46% | 611,076 | 2.69B |
| 181 | ABVX | ABIVAX Société Anonyme | 447.62M | 3.55% | 118,948 | 11.44M |
| 182 | ATYR | aTyr Pharma, Inc. | 442.35M | -6.40% | 1,850,254 | 235.00K |
| 183 | ATAI | Atai Life Sciences N.V. | 437.64M | -3.11% | 639,367 | 1.86M |
| 184 | IVA | Inventiva S.A. | 430.63M | -3.65% | 5,228 | 14.59M |
| 185 | TRML | Tourmaline Bio, Inc. | 423.60M | -1.32% | 46,833 | - |
| 186 | PRTC | PureTech Health plc | 423.59M | -5.69% | 28,595 | 4.83M |
| 187 | MREO | Mereo BioPharma Group plc | 421.35M | -5.36% | 522,346 | 1.00M |
| 188 | RGNX | REGENXBIO Inc. | 421.25M | -4.46% | 313,210 | 156.72M |
| 189 | PGEN | Precigen, Inc. | 419.16M | -0.70% | 612,824 | 4.20M |
| 190 | RAPP | Rapport Therapeutics, Inc. | 413.15M | -4.15% | 26,222 | - |
| 191 | ZBIO | Zenas BioPharma, Inc. | 412.90M | -2.76% | 39,244 | 15.00M |
| 192 | ORKA | Oruka Therapeutics, Inc. | 409.22M | -6.02% | 128,564 | - |
| 193 | AURA | Aura Biosciences, Inc. | 389.08M | -0.24% | 45,966 | - |
| 194 | ITOS | iTeos Therapeutics, Inc. | 382.36M | -0.30% | 299,080 | 35.00M |
| 195 | FULC | Fulcrum Therapeutics, Inc. | 380.55M | -4.47% | 367,552 | 80.00M |
| 196 | CTMX | CytomX Therapeutics, Inc. | 374.17M | 2.81% | 803,440 | 147.56M |
| 197 | ARCT | Arcturus Therapeutics Holdings Inc. | 371.55M | -4.93% | 281,017 | 143.68M |
| 198 | VIGL | Vigil Neuroscience, Inc. | 370.81M | -0.06% | 158,741 | - |
| 199 | RZLT | Rezolute, Inc. | 369.44M | 0.23% | 546,254 | - |
| 200 | TECX | Tectonic Therapeutic, Inc. | 369.16M | -1.47% | 118,205 | - |
| 201 | ERAS | Erasca, Inc. | 365.44M | 2.38% | 382,723 | - |
| 202 | SLDB | Solid Biosciences Inc. | 362.00M | -2.91% | 323,595 | - |
| 203 | MBX | MBX Biosciences, Inc. | 359.31M | -4.78% | 83,038 | - |
| 204 | CMPX | Compass Therapeutics, Inc. | 354.69M | -1.35% | 616,738 | 850.00K |
| 205 | RIGL | Rigel Pharmaceuticals, Inc. | 347.62M | 3.68% | 107,202 | 203.08M |
| 206 | ABSI | Absci Corporation | 336.76M | -2.58% | 2,411,570 | 4.82M |
| 207 | TERN | Terns Pharmaceuticals, Inc. | 332.76M | -4.75% | 339,506 | - |
| 208 | NKTR | Nektar Therapeutics | 329.90M | -10.41% | 2,778,105 | 87.25M |
| 209 | HUMA | Humacyte, Inc. | 329.63M | -4.28% | 857,721 | 517.00K |
| 210 | PRTA | Prothena Corporation plc | 329.42M | -0.97% | 1,149,247 | 137.94M |
| 211 | XOMA | XOMA Royalty Corporation | 328.13M | 0.37% | 44,366 | 42.91M |
| 212 | HRTX | Heron Therapeutics, Inc. | 324.20M | -1.62% | 559,152 | 148.52M |
| 213 | OLMA | Olema Pharmaceuticals, Inc. | 311.32M | -0.22% | 194,924 | - |
| 214 | ATXS | Astria Therapeutics, Inc. | 311.23M | 1.38% | 74,008 | - |
| 215 | LXRX | Lexicon Pharmaceuticals, Inc. | 307.25M | -8.96% | 2,860,501 | 31.21M |
| 216 | PRME | Prime Medicine, Inc. | 306.13M | -9.62% | 2,657,155 | 3.85M |
| 217 | CRVS | Corvus Pharmaceuticals, Inc. | 301.90M | -7.01% | 570,494 | - |
| 218 | AVIR | Atea Pharmaceuticals, Inc. | 298.67M | -1.13% | 176,751 | - |
| 219 | AARD | Aardvark Therapeutics, Inc. | 297.88M | -0.94% | 29,126 | - |
| 220 | JBIO | Jade Biosciences, Inc. | 297.86M | -0.11% | 109,273 | - |
| 221 | BNTC | Benitec Biopharma Inc. | 296.11M | -8.66% | 139,858 | - |
| 222 | ABEO | Abeona Therapeutics Inc. | 294.92M | -2.29% | 611,902 | - |
| 223 | OCGN | Ocugen, Inc. | 292.03M | -2.91% | 7,528,193 | 4.52M |
| 224 | GOSS | Gossamer Bio, Inc. | 289.81M | -1.92% | 1,861,298 | 124.59M |
| 225 | ALT | Altimmune, Inc. | 287.93M | -1.66% | 13,268,474 | 20.00K |
| 226 | VNDA | Vanda Pharmaceuticals Inc. | 286.72M | 0.93% | 274,906 | 201.35M |
| 227 | GLUE | Monte Rosa Therapeutics, Inc. | 280.48M | -2.15% | 95,461 | 159.49M |
| 228 | RNAC | Cartesian Therapeutics, Inc. | 274.60M | -7.68% | 35,532 | 34.17M |
| 229 | SLN | Silence Therapeutics plc | 274.41M | 4.87% | 102,824 | 27.70M |
| 230 | RCKT | Rocket Pharmaceuticals, Inc. | 271.50M | -2.70% | 1,485,740 | - |
| 231 | ADCT | ADC Therapeutics SA | 266.29M | -0.56% | 599,141 | 75.82M |
| 232 | ANNX | Annexon, Inc. | 264.41M | -1.63% | 376,681 | - |
| 233 | FHTX | Foghorn Therapeutics Inc. | 261.98M | -3.29% | 28,964 | 23.50M |
| 234 | INZY | Inozyme Pharma, Inc. | 259.66M | - | 527,704 | - |
| 235 | ALLO | Allogene Therapeutics, Inc. | 259.20M | -1.25% | 1,170,921 | 22.00K |
| 236 | LIMN | Liminatus Pharma, Inc. | 258.33M | -40.18% | 530,196 | - |
| 237 | DRTS | Alpha Tau Medical Ltd. | 257.91M | 1.00% | 18,223 | - |
| 238 | CBIO | Crescent Biopharma, Inc. | 256.46M | 1.48% | 13,927 | - |
| 239 | TNXP | Tonix Pharmaceuticals Holding Corp. | 250.99M | -4.64% | 441,590 | 10.04M |
| 240 | DBVT | DBV Technologies S.A. | 249.55M | -1.36% | 8,970 | 3.50M |
| 241 | PVLA | Palvella Therapeutics, Inc. | 247.70M | 8.66% | 160,504 | - |
| 242 | SGMT | Sagimet Biosciences Inc. | 247.58M | -11.61% | 1,267,589 | - |
| 243 | THRD | Third Harmonic Bio, Inc. | 245.27M | -0.28% | 32,189 | - |
| 244 | CADL | Candel Therapeutics, Inc. | 245.00M | -2.78% | 432,620 | - |
| 245 | TRDA | Entrada Therapeutics, Inc. | 242.57M | -1.99% | 32,353 | 172.22M |
| 246 | TENX | Tenax Therapeutics, Inc. | 236.97M | - | 4,943 | - |
| 247 | LCTX | Lineage Cell Therapeutics, Inc. | 235.21M | 6.81% | 1,574,840 | 9.56M |
| 248 | NGNE | Neurogene Inc. | 232.12M | -1.78% | 53,478 | 925.00K |
| 249 | PRQR | ProQR Therapeutics N.V. | 230.70M | 1.39% | 757,789 | 21.21M |
| 250 | IMMP | Immutep Limited | 229.40M | -0.61% | 39,540 | 3.02M |
| 251 | ALDX | Aldeyra Therapeutics, Inc. | 227.60M | -1.81% | 812,749 | - |
| 252 | VSTM | Verastem, Inc. | 226.12M | -1.08% | 1,921,146 | 10.00M |
| 253 | TVRD | Tvardi Therapeutics, Inc. | 225.60M | -4.40% | 24,117 | - |
| 254 | NBTX | Nanobiotix S.A. | 224.60M | -1.94% | 1,431 | -7.44M |
| 255 | LXEO | Lexeo Therapeutics, Inc. | 222.14M | -3.11% | 114,334 | - |
| 256 | FENC | Fennec Pharmaceuticals Inc. | 220.67M | -3.50% | 19,149 | 30.91M |
| 257 | TVGN | Tevogen Bio Holdings Inc. | 213.90M | -1.72% | 301,160 | - |
| 258 | YMAB | Y-mAbs Therapeutics, Inc. | 210.17M | -3.33% | 50,429 | 88.66M |
| 259 | INBX | Inhibrx Biosciences, Inc. | 210.04M | -1.90% | 19,886 | 200.00K |
| 260 | PROK | ProKidney Corp. | 209.55M | -0.97% | 311,109 | 306.00K |
| 261 | MDWD | MediWound Ltd. | 208.91M | -0.31% | 15,641 | 19.21M |
| 262 | CRDF | Cardiff Oncology, Inc. | 208.56M | -0.79% | 729,772 | 587.00K |
| 263 | OABI | OmniAb, Inc. | 205.52M | -0.59% | 161,850 | 26.74M |
| 264 | IMAB | I-Mab | 204.97M | 24.26% | 2,371,048 | 569.46K |
| 265 | DSGN | Design Therapeutics, Inc. | 204.93M | -5.50% | 24,675 | - |
| 266 | SCPH | scPharmaceuticals Inc. | 202.19M | -3.77% | 53,428 | 41.98M |
| 267 | ACIU | AC Immune SA | 200.85M | -2.87% | 89,126 | 32.01M |
| 268 | MNPR | Monopar Therapeutics Inc. | 198.74M | -7.17% | 12,478 | - |
| 269 | KOD | Kodiak Sciences Inc. | 195.26M | -1.85% | 109,019 | - |
| 270 | GNFT | Genfit S.A. | 195.15M | -3.52% | 15,489 | 73.19M |
| 271 | CRGX | CARGO Therapeutics, Inc. | 194.83M | 0.12% | 135,833 | - |
| 272 | CDXS | Codexis, Inc. | 194.69M | -6.75% | 375,084 | 49.82M |
| 273 | OMER | Omeros Corporation | 193.36M | -0.60% | 459,929 | - |
| 274 | LRMR | Larimar Therapeutics, Inc. | 189.52M | -3.90% | 415,604 | - |
| 275 | TLSA | Tiziana Life Sciences Ltd | 189.49M | -4.49% | 288,855 | - |
| 276 | DRUG | Bright Minds Biosciences Inc. | 188.95M | -4.48% | 28,784 | - |
| 277 | SLS | SELLAS Life Sciences Group, Inc. | 187.08M | -7.64% | 1,975,253 | - |
| 278 | EDIT | Editas Medicine, Inc. | 185.42M | 4.48% | 2,333,361 | 35.84M |
| 279 | ENGN | enGene Holdings Inc. | 184.49M | 0.56% | 38,943 | - |
| 280 | ENGNW | enGene Holdings Inc. | 183.47M | -3.42% | 450 | - |
| 281 | FDMT | 4D Molecular Therapeutics, Inc. | 182.75M | -3.07% | 121,691 | 23.00K |
| 282 | NVCT | Nuvectis Pharma, Inc. | 180.10M | -1.17% | 76,970 | - |
| 283 | CYBN | Cybin Inc. | 174.07M | -3.55% | 99,119 | - |
| 284 | VTYX | Ventyx Biosciences, Inc. | 173.63M | -0.41% | 869,052 | - |
| 285 | EPRX | Eupraxia Pharmaceuticals Inc. | 167.68M | 11.04% | 20,490 | - |
| 286 | IPHA | Innate Pharma S.A. | 166.68M | 0.52% | 2,386 | 20.83M |
| 287 | SPRO | Spero Therapeutics, Inc. | 165.50M | 2.07% | 1,359,174 | 44.58M |
| 288 | ALMS | Alumis Inc. | 164.85M | -8.18% | 392,081 | 17.39M |
| 289 | PBYI | Puma Biotechnology, Inc. | 163.31M | -0.60% | 143,839 | 232.71M |
| 290 | DMAC | DiaMedica Therapeutics Inc. | 159.96M | -2.10% | 136,575 | - |
| 291 | ENTA | Enanta Pharmaceuticals, Inc. | 159.04M | -0.93% | 74,484 | 64.46M |
| 292 | VYGR | Voyager Therapeutics, Inc. | 158.82M | -3.37% | 195,786 | 66.96M |
| 293 | ELDN | Eledon Pharmaceuticals, Inc. | 157.49M | -4.36% | 269,431 | - |
| 294 | ACRS | Aclaris Therapeutics, Inc. | 155.92M | -7.69% | 629,499 | 17.78M |
| 295 | GALT | Galectin Therapeutics Inc. | 155.38M | 4.47% | 197,092 | - |
| 296 | CGEN | Compugen Ltd. | 152.43M | - | 95,523 | 27.59M |
| 297 | KYTX | Kyverna Therapeutics, Inc. | 145.65M | -2.88% | 494,666 | - |
| 298 | ALEC | Alector, Inc. | 144.99M | -3.33% | 184,075 | 88.34M |
| 299 | ACOG | Alpha Cognition Inc. | 144.34M | -2.17% | 35,062 | 2.93M |
| 300 | TIL | Instil Bio, Inc. | 143.66M | -1.22% | 176,947 | - |
| 301 | SKYE | Skye Bioscience, Inc. | 143.30M | 8.82% | 3,747,001 | - |
| 302 | RAPT | RAPT Therapeutics, Inc. | 141.05M | -12.33% | 49,848 | - |
| 303 | BDTX | Black Diamond Therapeutics, Inc. | 139.31M | -0.41% | 714,526 | 70.00M |
| 304 | MOLN | Molecular Partners AG | 136.61M | 1.40% | 247 | 2.53M |
| 305 | AGEN | Agenus Inc. | 136.54M | 1.43% | 607,299 | 99.52M |
| 306 | VOR | Vor Biopharma Inc. | 133.71M | 20.22% | 43,347,760 | - |
| 307 | IMRX | Immuneering Corporation | 130.99M | 14.11% | 2,327,332 | - |
| 308 | ASMB | Assembly Biosciences, Inc. | 130.37M | -0.06% | 17,477 | 32.15M |
| 309 | NMRA | Neumora Therapeutics, Inc. | 129.12M | -0.14% | 261,017 | - |
| 310 | SGMO | Sangamo Therapeutics, Inc. | 128.85M | -2.69% | 2,463,827 | 63.76M |
| 311 | LYEL | Lyell Immunopharma, Inc. | 128.31M | -4.99% | 53,694 | 65.00K |
| 312 | CUPR | Cuprina Holdings (Cayman) Limited | 126.77M | 1.03% | 16,813 | 35.41K |
| 313 | ELTX | Elicio Therapeutics, Inc. | 126.02M | -0.19% | 31,414 | - |
| 314 | MIST | Milestone Pharmaceuticals Inc. | 125.45M | -2.58% | 870,350 | - |
| 315 | SEER | Seer, Inc. | 124.75M | 2.91% | 93,471 | 15.31M |
| 316 | CRBU | Caribou Biosciences, Inc. | 123.70M | -1.48% | 592,183 | 9.92M |
| 317 | INMB | INmune Bio, Inc. | 121.39M | -16.72% | 53,873,301 | 50.00K |
| 318 | NKTX | Nkarta, Inc. | 120.63M | -1.73% | 158,885 | - |
| 319 | FATE | Fate Therapeutics, Inc. | 119.79M | -5.00% | 1,243,476 | 13.34M |
| 320 | GLSI | Greenwich LifeSciences, Inc. | 118.44M | -0.78% | 4,896 | - |
| 321 | IKT | Inhibikase Therapeutics, Inc. | 117.46M | -4.24% | 203,004 | 1.00 |
| 322 | ATOS | Atossa Therapeutics, Inc. | 116.54M | 2.83% | 519,721 | - |
| 323 | PLX | Protalix BioTherapeutics, Inc. | 115.83M | 0.34% | 386,095 | 59.76M |
| 324 | ACTU | Actuate Therapeutics, Inc. | 114.68M | 0.43% | 214,903 | - |
| 325 | OBIO | Orchestra BioMed Holdings, Inc. | 113.02M | -1.01% | 106,213 | 2.89M |
| 326 | KRRO | Korro Bio, Inc. | 112.69M | -2.76% | 27,049 | 4.82M |
| 327 | VXRT | Vaxart, Inc. | 111.94M | -7.89% | 2,113,808 | 47.40M |
| 328 | CTNM | Contineum Therapeutics, Inc. | 110.73M | 6.73% | 66,967 | - |
| 329 | TARA | Protara Therapeutics, Inc. | 110.73M | -3.69% | 276,558 | - |
| 330 | GNLX | Genelux Corporation | 110.41M | -2.95% | 26,882 | 8.00K |
| 331 | THTX | Theratechnologies Inc. | 107.87M | 1.71% | 151,920 | 88.67M |
| 332 | BMEA | Biomea Fusion, Inc. | 107.77M | -5.03% | 501,860 | - |
| 333 | CLLS | Cellectis S.A. | 106.38M | -4.56% | 46,975 | 54.75M |
| 334 | TNYA | Tenaya Therapeutics, Inc. | 105.57M | -6.15% | 1,413,638 | - |
| 335 | VTVT | vTv Therapeutics Inc. | 104.97M | -5.79% | 47,029 | 17.00K |
| 336 | ANIX | Anixa Biosciences, Inc. | 103.56M | -4.88% | 65,761 | - |
| 337 | CCCC | C4 Therapeutics, Inc. | 102.25M | -5.26% | 243,779 | 39.78M |
| 338 | BYSI | BeyondSpring Inc. | 101.80M | 0.20% | 3,558 | 1.88M |
| 339 | CSBR | Champions Oncology, Inc. | 101.57M | 2.63% | 30,924 | 58.59M |
| 340 | HLVX | HilleVax, Inc. | 97.48M | 0.77% | 103,149 | - |
| 341 | COYA | Coya Therapeutics, Inc. | 96.67M | -2.03% | 54,161 | 3.69M |
| 342 | IOBT | IO Biotech, Inc. | 95.53M | -2.03% | 56,596 | - |
| 343 | NAUT | Nautilus Biotechnology, Inc. | 93.77M | -7.89% | 174,431 | - |
| 344 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 93.23M | -5.00% | 83,642 | - |
| 345 | HURA | TuHURA Biosciences, Inc. | 92.60M | -7.42% | 201,986 | - |
| 346 | IVVD | Invivyd, Inc. | 92.60M | -3.38% | 587,098 | 36.69M |
| 347 | OKYO | OKYO Pharma Limited | 90.94M | 0.21% | 18,459 | - |
| 348 | ADAG | Adagene Inc. | 90.45M | 1.05% | 759 | 103.20K |
| 349 | VERU | Veru Inc. | 90.38M | -5.91% | 1,040,913 | 16.89M |
| 350 | ZNTL | Zentalis Pharmaceuticals, Inc. | 90.30M | -0.40% | 389,610 | 26.87M |
| 351 | XBIT | XBiotech Inc. | 88.72M | 1.39% | 61,187 | - |
| 352 | ENTX | Entera Bio Ltd. | 88.63M | -2.50% | 15,327 | 223.00K |
| 353 | CABA | Cabaletta Bio, Inc. | 87.77M | -3.24% | 766,976 | - |
| 354 | WHWK | Whitehawk Therapeutics, Inc. | 87.15M | -2.63% | 55,901 | 27.78M |
| 355 | NTRB | Nutriband Inc. | 86.93M | -0.25% | 46,658 | 2.40M |
| 356 | CHRS | Coherus Oncology, Inc. | 86.61M | 1.98% | 788,037 | 272.25M |
| 357 | SAVA | Cassava Sciences, Inc. | 86.47M | -2.19% | 485,535 | - |
| 358 | ORMP | Oramed Pharmaceuticals Inc. | 86.19M | -2.76% | 47,411 | 2.00M |
| 359 | UNCY | Unicycive Therapeutics, Inc. | 85.96M | 14.48% | 1,257,956 | - |
| 360 | GUTS | Fractyl Health, Inc. | 84.24M | -1.15% | 258,088 | 60.00K |
| 361 | JSPR | Jasper Therapeutics, Inc. | 83.37M | -2.46% | 116,500 | - |
| 362 | CLYM | Climb Bio, Inc. | 83.12M | -2.38% | 68,811 | - |
| 363 | TCRX | TScan Therapeutics, Inc. | 82.62M | -1.35% | 223,508 | 4.42M |
| 364 | FBRX | Forte Biosciences, Inc. | 82.23M | 9.47% | 173,050 | - |
| 365 | EXOZ | eXoZymes, Inc. | 81.67M | 0.36% | 1,273 | -700.00 |
| 366 | MCRB | Seres Therapeutics, Inc. | 79.20M | -4.63% | 50,809 | - |
| 367 | ACHV | Achieve Life Sciences, Inc. | 78.74M | -35.33% | 7,722,295 | - |
| 368 | PLRX | Pliant Therapeutics, Inc. | 78.57M | -1.54% | 375,182 | - |
| 369 | INO | Inovio Pharmaceuticals, Inc. | 78.48M | -4.89% | 267,768 | 283.10K |
| 370 | MGNX | MacroGenics, Inc. | 77.60M | -3.15% | 412,056 | 154.05M |
| 371 | VANI | Vivani Medical, Inc. | 77.02M | -0.76% | 86,051 | - |
| 372 | SRZN | Surrozen, Inc. | 76.89M | 7.54% | 9,043 | 11.64M |
| 373 | EPIX | ESSA Pharma Inc. | 76.35M | -1.15% | 28,500 | - |
| 374 | CBUS | Cibus, Inc. | 73.14M | -5.19% | 277,077 | 4.75M |
| 375 | IGMS | IGM Biosciences, Inc. | 72.74M | -0.82% | 46,907 | 2.68M |
| 376 | OTLK | Outlook Therapeutics, Inc. | 72.42M | -3.43% | 574,483 | - |
| 377 | PYXS | Pyxis Oncology, Inc. | 71.55M | -2.12% | 253,886 | 16.15M |
| 378 | ABOS | Acumen Pharmaceuticals, Inc. | 70.87M | -3.31% | 124,448 | - |
| 379 | QNCX | Quince Therapeutics, Inc. | 69.57M | 2.00% | 109,050 | - |
| 380 | ARMP | Armata Pharmaceuticals, Inc. | 68.77M | -0.52% | 9,787 | 4.70M |
| 381 | ZURA | Zura Bio Limited | 68.37M | -3.91% | 141,505 | - |
| 382 | IMUX | Immunic, Inc. | 67.17M | -1.32% | 361,653 | - |
| 383 | NTHI | NeOnc Technologies Holdings, Inc. | 67.16M | -11.53% | 11,096 | 79.99K |
| 384 | ANRO | Alto Neuroscience, Inc. | 65.92M | 5.87% | 140,619 | - |
| 385 | IKNA | Ikena Oncology, Inc. | 65.15M | 0.75% | 10,277 | - |
| 386 | STRO | Sutro Biopharma, Inc. | 64.39M | -4.58% | 262,409 | 66.43M |
| 387 | PDSB | PDS Biotechnology Corporation | 63.99M | -3.45% | 168,697 | - |
| 388 | QNTM | Quantum BioPharma Ltd. | 63.96M | 4.36% | 238,541 | - |
| 389 | ONCY | Oncolytics Biotech Inc. | 63.81M | 4.83% | 1,176,370 | - |
| 390 | ADAP | Adaptimmune Therapeutics plc | 63.37M | -1.28% | 641,178 | 179.64M |
| 391 | MNOV | MediciNova, Inc. | 63.27M | -0.77% | 2,913 | - |
| 392 | CLSD | Clearside Biomedical, Inc. | 61.39M | -2.59% | 79,099 | 3.76M |
| 393 | RPTX | Repare Therapeutics Inc. | 60.05M | -0.71% | 95,203 | 1.07M |
| 394 | EYEN | Eyenovia, Inc. | 59.82M | 48.54% | 5,065,822 | 67.06K |
| 395 | ATHE | Alterity Therapeutics Limited | 59.74M | 3.32% | 55,420 | 2.30M |
| 396 | IRD | Opus Genetics, Inc. | 59.66M | -1.96% | 564,779 | 13.65M |
| 397 | IMMX | Immix Biopharma, Inc. | 59.33M | -4.91% | 90,549 | - |
| 398 | ICCC | ImmuCell Corporation | 59.19M | -3.53% | 11,597 | 27.30M |
| 399 | CUE | Cue Biopharma, Inc. | 58.40M | -1.82% | 65,386 | 7.99M |
| 400 | SER | Serina Therapeutics, Inc. | 58.26M | -4.65% | 2,781 | 51.00K |
| 401 | GANX | Gain Therapeutics, Inc. | 58.23M | -1.01% | 197,800 | - |
| 402 | NRXP | NRx Pharmaceuticals, Inc. | 58.09M | -4.00% | 127,040 | - |
| 403 | ANEB | Anebulo Pharmaceuticals, Inc. | 57.93M | -0.70% | - | - |
| 404 | MGX | Metagenomi, Inc. | 57.57M | -3.14% | 305,750 | 45.26M |
| 405 | ANL | Adlai Nortye Ltd. | 57.56M | 0.64% | 4 | 1.94M |
| 406 | VTGN | Vistagen Therapeutics, Inc. | 57.44M | -3.90% | 158,405 | 486.00K |
| 407 | RENB | Renovaro Inc. | 56.90M | -5.30% | 529,620 | - |
| 408 | CRVO | CervoMed Inc. | 56.83M | -8.09% | 65,017 | 9.31M |
| 409 | CNTB | Connect Biopharma Holdings Limited | 56.67M | 5.10% | 25,393 | 26.03M |
| 410 | CNTX | Context Therapeutics Inc. | 56.60M | -3.12% | 55,958 | - |
| 411 | SNTI | Senti Biosciences, Inc. | 56.60M | 2.84% | 44,079 | - |
| 412 | GNTA | Genenta Science S.p.A. | 56.52M | 1.48% | 17,418 | - |
| 413 | IFRX | InflaRx N.V. | 56.23M | -0.31% | 135,317 | 140.24K |
| 414 | ACET | Adicet Bio, Inc. | 55.89M | 0.76% | 61,511 | - |
| 415 | PMVP | PMV Pharmaceuticals, Inc. | 55.59M | -0.93% | 49,587 | - |
| 416 | FBIO | Fortress Biotech, Inc. | 53.52M | -2.16% | 95,060 | 57.78M |
| 417 | MAIA | MAIA Biotechnology, Inc. | 53.04M | 0.57% | 103,335 | - |
| 418 | OSTX | OS Therapies Incorporated | 52.40M | 3.04% | 190,827 | - |
| 419 | ADVM | Adverum Biotechnologies, Inc. | 52.02M | - | 85,464 | 1.00M |
| 420 | APLT | Applied Therapeutics, Inc. | 51.70M | -3.89% | 717,596 | 265.00K |
| 421 | AVTX | Avalo Therapeutics, Inc. | 50.79M | -1.46% | 13,329 | 441.00K |
| 422 | VRCA | Verrica Pharmaceuticals Inc. | 50.62M | -6.05% | 137,107 | 7.18M |
| 423 | IPA | ImmunoPrecise Antibodies Ltd. | 50.35M | -0.88% | 861,076 | 16.58M |
| 424 | KLRS | Kalaris Therapeutics, Inc. | 49.37M | 3.13% | 17,590 | - |
| 425 | ATNM | Actinium Pharmaceuticals, Inc. | 49.13M | -2.78% | 101,153 | 81.00K |
| 426 | IPSC | Century Therapeutics, Inc. | 48.21M | -1.43% | 399,464 | 114.90M |
| 427 | HOWL | Werewolf Therapeutics, Inc. | 48.01M | -6.14% | 295,849 | 1.14M |
| 428 | DTIL | Precision BioSciences, Inc. | 47.79M | 4.11% | 257,772 | 51.14M |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 47.62M | -5.88% | 71,043 | - |
| 430 | STTK | Shattuck Labs, Inc. | 47.55M | -0.73% | 108,168 | 4.61M |
| 431 | ATRA | Atara Biotherapeutics, Inc. | 47.37M | -0.05% | 10,653 | 199.73M |
| 432 | RNXT | RenovoRx, Inc. | 47.18M | -4.44% | 199,930 | 240.00K |
| 433 | PRLD | Prelude Therapeutics Incorporated | 46.75M | -3.71% | 98,409 | 7.00M |
| 434 | CELU | Celularity Inc. | 44.79M | -2.09% | 11,027 | 54.22M |
| 435 | NRSN | NeuroSense Therapeutics Ltd. | 43.90M | -7.58% | 382,466 | - |
| 436 | ALGS | Aligos Therapeutics, Inc. | 43.72M | 0.14% | 53,686 | 3.27M |
| 437 | MURA | Mural Oncology plc | 42.48M | -0.81% | 16,274 | - |
| 438 | ANVS | Annovis Bio, Inc. | 41.12M | -2.76% | 334,614 | - |
| 439 | GRCE | Grace Therapeutics, Inc. | 40.79M | 0.34% | 15,283 | - |
| 440 | PLUR | Pluri Inc. | 40.57M | 1.57% | 10,191 | 1.03M |
| 441 | ABVC | ABVC BioPharma, Inc. | 40.55M | 13.93% | 604,815 | 508.38K |
| 442 | ITRM | Iterum Therapeutics plc | 40.00M | -1.96% | 270,518 | - |
| 443 | MRSN | Mersana Therapeutics, Inc. | 39.88M | -1.54% | 1,177,427 | 34.01M |
| 444 | ACRV | Acrivon Therapeutics, Inc. | 39.82M | -3.05% | 175,448 | - |
| 445 | PEPG | PepGen Inc. | 39.27M | -6.25% | 127,170 | - |
| 446 | ARTV | Artiva Biotherapeutics, Inc. | 38.49M | 0.64% | 88,160 | 251.00K |
| 447 | KPTI | Karyopharm Therapeutics Inc. | 37.93M | -2.23% | 17,692 | 142.13M |
| 448 | BRNS | Barinthus Biotherapeutics plc | 37.35M | 0.38% | 617 | 14.97M |
| 449 | AKTX | Akari Therapeutics, Plc | 37.32M | -0.85% | 23,886 | - |
| 450 | PYPD | PolyPid Ltd. | 36.28M | -0.55% | 94,074 | - |
| 451 | XCUR | Exicure, Inc. | 35.70M | 1.89% | 8,414 | 500.00K |
| 452 | XLO | Xilio Therapeutics, Inc. | 34.62M | -1.60% | 140,650 | 9.27M |
| 453 | LVTX | LAVA Therapeutics N.V. | 34.59M | 0.77% | 4,016 | 4.99M |
| 454 | RADX | Radiopharm Theranostics Limited | 33.99M | 2.47% | 19,513 | 204.61K |
| 455 | LTRN | Lantern Pharma Inc. | 33.97M | 0.32% | 20,379 | - |
| 456 | JUNS | Jupiter Neurosciences, Inc. | 33.43M | -6.48% | 255,906 | - |
| 457 | RANI | Rani Therapeutics Holdings, Inc. | 33.14M | 11.41% | 472,935 | 1.20M |
| 458 | ANTX | AN2 Therapeutics, Inc. | 32.89M | 0.93% | 22,605 | - |
| 459 | RNTX | Rein Therapeutics Inc. | 32.57M | 1.38% | 85,597 | - |
| 460 | OKUR | OnKure Therapeutics, Inc. | 32.35M | -4.97% | 59,266 | - |
| 461 | ESLA | Estrella Immunopharma, Inc. | 32.05M | -5.72% | 5,796 | - |
| 462 | KZR | Kezar Life Sciences, Inc. | 31.78M | 1.87% | 26,982 | - |
| 463 | CAMP | Camp4 Therapeutics Corporation | 31.65M | 5.37% | 186,384 | 1.51M |
| 464 | KALA | KALA BIO, Inc. | 30.49M | -10.09% | 137,755 | - |
| 465 | DYAI | Dyadic International, Inc. | 30.09M | 0.49% | 113,406 | 3.55M |
| 466 | MLEC | Moolec Science SA | 29.49M | -4.23% | 67,586 | 7.83M |
| 467 | TPST | Tempest Therapeutics, Inc. | 28.45M | -1.83% | 59,140 | - |
| 468 | ENLV | Enlivex Therapeutics Ltd. | 28.07M | -2.07% | 35,337 | - |
| 469 | FBLG | FibroBiologics, Inc. | 28.01M | 0.25% | 187,893 | - |
| 470 | INKT | MiNK Therapeutics, Inc. | 27.90M | -6.04% | 662 | - |
| 471 | COEP | Coeptis Therapeutics Holdings, Inc. | 27.41M | -2.86% | 10,800 | 62.87K |
| 472 | OSRH | OSR Holdings, Inc. | 27.18M | 12.80% | 73,559 | -148.95K |
| 473 | GDTC | CytoMed Therapeutics Limited | 26.89M | 1.30% | 227 | 368.84K |
| 474 | PBM | Psyence Biomedical Ltd. | 26.80M | -1.84% | 7,945 | - |
| 475 | PULM | Pulmatrix, Inc. | 25.34M | -0.19% | 3,247 | 1.92M |
| 476 | IGC | IGC Pharma, Inc. | 24.54M | -0.65% | 133,018 | 1.24M |
| 477 | OVID | Ovid Therapeutics Inc. | 24.40M | 0.06% | 1,012,832 | 548.00K |
| 478 | LSTA | Lisata Therapeutics, Inc. | 24.33M | -3.74% | 31,224 | 1.00M |
| 479 | VYNE | VYNE Therapeutics Inc. | 24.16M | -10.49% | 975,892 | 605.00K |
| 480 | NRXS | NeurAxis, Inc. | 23.72M | -1.19% | 35,409 | 2.93M |
| 481 | BOLD | Boundless Bio, Inc. | 23.62M | -1.40% | 83,120 | - |
| 482 | CRIS | Curis, Inc. | 23.23M | - | 19,728 | 11.20M |
| 483 | ALXO | ALX Oncology Holdings Inc. | 23.19M | -4.11% | 241,370 | - |
| 484 | KLTO | Klotho Neurosciences, Inc. | 23.16M | -36.92% | 6,293,944 | - |
| 485 | GBIO | Generation Bio Co. | 22.95M | -3.60% | 754,121 | 24.56M |
| 486 | BCAB | BioAtla, Inc. | 22.80M | 4.05% | 257,103 | 11.00M |
| 487 | CMMB | Chemomab Therapeutics Ltd. | 22.52M | -1.56% | 41,638 | - |
| 488 | ELEV | Elevation Oncology, Inc. | 22.49M | -1.43% | 216,676 | - |
| 489 | NNVC | NanoViricides, Inc. | 22.18M | 12.20% | 595,431 | - |
| 490 | PASG | Passage Bio, Inc. | 22.04M | 7.48% | 262,119 | - |
| 491 | FGEN | FibroGen, Inc. | 21.42M | - | 35,004 | 7.00M |
| 492 | DARE | Daré Bioscience, Inc. | 21.33M | -8.37% | 48,305 | 25.91K |
| 493 | CALC | CalciMedica, Inc. | 21.17M | 5.94% | 41,492 | - |
| 494 | BCTX | BriaCell Therapeutics Corp. | 20.96M | -2.57% | 52,597 | - |
| 495 | CVKD | Cadrenal Therapeutics, Inc. | 20.67M | 2.24% | 19,516 | - |
| 496 | RLMD | Relmada Therapeutics, Inc. | 20.61M | -7.74% | 142,934 | - |
| 497 | APUS | Apimeds Pharmaceuticals US, Inc. | 20.37M | 2.43% | 19,952 | - |
| 498 | SLGL | Sol-Gel Technologies Ltd. | 20.33M | -1.12% | 3,029 | 12.10M |
| 499 | LGVN | Longeveron Inc. | 19.66M | 0.77% | 154,133 | 2.23M |
| 500 | CGTX | Cognition Therapeutics, Inc. | 19.22M | -4.47% | 886,024 | - |
| 501 | QTTB | Q32 Bio Inc. | 19.03M | 0.65% | 27,449 | - |
| 502 | CASI | CASI Pharmaceuticals, Inc. | 18.90M | -6.15% | 24,139 | 31.37M |
| 503 | BLRX | BioLineRx Ltd. | 18.86M | 0.45% | 45,742 | 22.34M |
| 504 | BIVI | BioVie Inc. | 18.62M | -2.49% | 264,009 | - |
| 505 | MEIP | MEI Pharma, Inc. | 18.62M | 3.90% | 20,738 | - |
| 506 | LSB | LakeShore Biopharma Co., Ltd | 17.94M | -0.53% | 12,239 | 79.42M |
| 507 | CARM | Carisma Therapeutics, Inc. | 17.48M | 2.95% | 604,701 | 19.96M |
| 508 | CTXR | Citius Pharmaceuticals, Inc. | 17.26M | 16.17% | 4,268,659 | - |
| 509 | LPCN | Lipocine Inc. | 17.20M | -0.16% | 28,095 | 3.67M |
| 510 | CING | Cingulate Inc. | 17.07M | -1.95% | 32,713 | - |
| 511 | MRKR | Marker Therapeutics, Inc. | 16.86M | 2.05% | 41,018 | 5.70M |
| 512 | LEXX | Lexaria Bioscience Corp. | 16.75M | 0.01% | 45,517 | 525.92K |
| 513 | SABS | SAB Biotherapeutics, Inc. | 16.50M | -0.23% | 1,957 | 377.84K |
| 514 | CLGN | CollPlant Biotechnologies Ltd. | 16.27M | 3.27% | 48,630 | 2.47M |
| 515 | IMNN | Imunon, Inc. | 16.23M | -4.61% | 569,603 | - |
| 516 | EVAX | Evaxion A/S | 15.97M | -2.22% | 39,362 | 3.29M |
| 517 | COCP | Cocrystal Pharma, Inc. | 15.87M | 0.66% | 26,333 | - |
| 518 | PMN | ProMIS Neurosciences, Inc. | 15.85M | 0.01% | 17,167 | - |
| 519 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 15.71M | -6.09% | 9,972,724 | - |
| 520 | PSTV | Plus Therapeutics, Inc. | 15.66M | -16.23% | 21,060,657 | 5.21M |
| 521 | ASBP | Aspire Biopharma Holdings, Inc. | 15.65M | 4.58% | 2,978,012 | - |
| 522 | HOOK | HOOKIPA Pharma Inc. | 15.59M | -1.58% | 7,573 | 9.35M |
| 523 | CANF | Can-Fite BioPharma Ltd. | 15.22M | 0.49% | 82,033 | 674.00K |
| 524 | ALLR | Allarity Therapeutics, Inc. | 14.80M | 0.26% | 165,621 | - |
| 525 | HOTH | Hoth Therapeutics, Inc. | 14.77M | -4.44% | 325,404 | - |
| 526 | SYBX | Synlogic, Inc. | 14.74M | 3.28% | 1,866 | 8.00K |
| 527 | CLRB | Cellectar Biosciences, Inc. | 14.35M | 7.32% | 89,862 | - |
| 528 | RLYB | Rallybio Corporation | 14.15M | -6.18% | 66,193 | 848.00K |
| 529 | EDSA | Edesa Biotech, Inc. | 13.97M | 1.90% | 2,143 | - |
| 530 | ERNA | Ernexa Therapeutics Inc. | 13.68M | -2.17% | 7,648 | 535.00K |
| 531 | UBX | Unity Biotechnology, Inc. | 13.49M | -0.19% | 20,434 | - |
| 532 | NEUP | Neuphoria Therapeutics Inc. | 13.25M | 3.68% | 38,975 | 15.66M |
| 533 | ABP | Abpro Holdings, Inc. | 13.03M | -3.88% | 2,066,121 | 183.00K |
| 534 | MTVA | MetaVia Inc. | 12.97M | -2.65% | 130,027 | - |
| 535 | NXTC | NextCure, Inc. | 12.93M | 0.22% | 88,595 | - |
| 536 | GOVX | GeoVax Labs, Inc. | 12.85M | -2.29% | 365,401 | 5.59M |
| 537 | LYRA | Lyra Therapeutics, Inc. | 12.37M | -30.23% | 603,201 | 1.19M |
| 538 | NERV | Minerva Neurosciences, Inc. | 12.31M | -2.22% | 10,029 | - |
| 539 | IBIO | iBio, Inc. | 12.26M | 6.46% | 1,739,109 | 375.00K |
| 540 | BRTX | BioRestorative Therapies, Inc. | 12.23M | -2.40% | 14,070 | 391.00K |
| 541 | ATHA | Athira Pharma, Inc. | 12.22M | 3.30% | 95,615 | - |
| 542 | CVM | CEL-SCI Corporation | 12.20M | -2.61% | 37,262 | - |
| 543 | EQ | Equillium, Inc. | 11.89M | -2.20% | 135,074 | 30.41M |
| 544 | LPTX | Leap Therapeutics, Inc. | 11.83M | 2.07% | 561,866 | - |
| 545 | PHGE | BiomX Inc. | 11.75M | -0.27% | 59,164 | - |
| 546 | EVGN | Evogene Ltd. | 11.74M | 1.59% | 81,854 | 6.77M |
| 547 | APVO | Aptevo Therapeutics Inc. | 11.47M | -4.18% | 218,810 | - |
| 548 | XFOR | X4 Pharmaceuticals, Inc. | 11.23M | -3.00% | 220,637 | 31.36M |
| 549 | KAPA | Kairos Pharma, Ltd. | 11.20M | -3.67% | 331,185 | - |
| 550 | GTBP | GT Biopharma, Inc. | 11.11M | -7.11% | 50,762 | - |
| 551 | BTAI | BioXcel Therapeutics, Inc. | 11.08M | -9.85% | 317,847 | 1.85M |
| 552 | BCDA | BioCardia, Inc. | 10.87M | -5.83% | 21,010 | 3.00K |
| 553 | SNSE | Sensei Biotherapeutics, Inc. | 10.84M | 2.63% | 7,089 | - |
| 554 | BOLT | Bolt Biotherapeutics, Inc. | 10.75M | -2.43% | 14,231 | 3.64M |
| 555 | CSCI | COSCIENS Biopharma Inc. | 10.57M | -5.93% | 178 | 9.03M |
| 556 | IMRN | Immuron Limited | 10.41M | -1.60% | 3,020 | 4.05M |
| 557 | PHIO | Phio Pharmaceuticals Corp. | 10.41M | -1.81% | 69,536 | - |
| 558 | ACXP | Acurx Pharmaceuticals, Inc. | 10.40M | -7.58% | 618,349 | - |
| 559 | XTLB | XTL Biopharmaceuticals Ltd. | 10.14M | -1.82% | 1,298 | 451.00K |
| 560 | APRE | Aprea Therapeutics, Inc. | 9.46M | -2.41% | 37,164 | 1.28M |
| 561 | CYCN | Cyclerion Therapeutics, Inc. | 9.41M | 4.37% | 41,811 | 2.08M |
| 562 | DWTX | Dogwood Therapeutics, Inc. | 9.13M | 0.20% | 11,241 | - |
| 563 | KPRX | Kiora Pharmaceuticals, Inc. | 9.13M | -0.99% | 16,779 | 20.00K |
| 564 | IBO | Impact BioMedical Inc. | 9.10M | -18.14% | 1,753,864 | - |
| 565 | PRTG | Portage Biotech Inc. | 8.97M | -8.56% | 32,707 | - |
| 566 | NLSP | NLS Pharmaceutics AG | 8.94M | 11.42% | 350,814 | - |
| 567 | CHRO | Channel Therapeutics Corporation | 8.90M | 15.38% | 1,683,074 | - |
| 568 | TCRT | Alaunos Therapeutics, Inc. | 8.67M | 5.38% | 26,900 | 11.00K |
| 569 | BCLI | Brainstorm Cell Therapeutics Inc. | 8.57M | -0.92% | 349,321 | - |
| 570 | AEON | AEON Biopharma, Inc. | 8.25M | -4.30% | 93,660 | - |
| 571 | TSBX | Turnstone Biologics Corp. | 8.10M | 5.33% | 2,637,739 | - |
| 572 | CLDI | Calidi Biotherapeutics, Inc. | 8.03M | 4.41% | 455,585 | - |
| 573 | INTS | Intensity Therapeutics, Inc. | 7.90M | 2.94% | 4,632,178 | - |
| 574 | TRAW | Traws Pharma, Inc. | 7.85M | -1.40% | 43,463 | 227.00K |
| 575 | SNPX | Synaptogenix, Inc. | 7.78M | 14.29% | 535,898 | - |
| 576 | HCWB | HCW Biologics Inc. | 7.54M | 2.61% | 3,400,144 | 1.45M |
| 577 | CYCC | Cyclacel Pharmaceuticals, Inc. | 7.51M | -3.63% | 351,262 | 14.00K |
| 578 | INAB | IN8bio, Inc. | 7.37M | -0.93% | 88,836 | - |
| 579 | ADXN | Addex Therapeutics Ltd | 7.27M | 4.37% | 60,267 | 278.51K |
| 580 | APLM | Apollomics, Inc. | 7.12M | 0.58% | 100 | 198.00K |
| 581 | CELZ | Creative Medical Technology Holdings, Inc. | 7.07M | -1.79% | 43,191 | 14.00K |
| 582 | KZIA | Kazia Therapeutics Limited | 7.03M | -3.68% | 47,911 | 1.55M |
| 583 | PMCB | PharmaCyte Biotech, Inc. | 7.01M | -2.86% | 2,721 | - |
| 584 | ICU | SeaStar Medical Holding Corporation | 6.94M | 2.41% | 2,232,768 | 428.00K |
| 585 | PPBT | Purple Biotech Ltd | 6.86M | -1.29% | 11,482 | - |
| 586 | APM | Aptorum Group Limited | 6.77M | -4.24% | 24,330 | - |
| 587 | SLXN | Silexion Therapeutics Corp | 6.71M | -1.74% | 27,552 | - |
| 588 | RNAZ | TransCode Therapeutics, Inc. | 6.67M | -2.47% | 11,875 | - |
| 589 | GNPX | Genprex, Inc. | 6.53M | -3.76% | 1,208,279 | - |
| 590 | INDP | Indaptus Therapeutics, Inc. | 6.36M | - | 38,006 | - |
| 591 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.17M | 7.58% | 75,825 | 19.90K |
| 592 | XBIO | Xenetic Biosciences, Inc. | 5.71M | -7.27% | 55,506 | 2.58M |
| 593 | KTTA | Pasithea Therapeutics Corp. | 5.65M | 3.41% | 104,012 | - |
| 594 | QNRX | Quoin Pharmaceuticals, Ltd. | 5.59M | -2.36% | 645 | - |
| 595 | PCSA | Processa Pharmaceuticals, Inc. | 5.56M | -10.87% | 5,314,603 | - |
| 596 | TTNP | Titan Pharmaceuticals, Inc. | 5.19M | - | 2,053 | - |
| 597 | ADIL | Adial Pharmaceuticals, Inc. | 4.98M | -32.87% | 13,488,032 | - |
| 598 | THAR | Tharimmune, Inc. | 4.83M | 3.12% | 39,717 | - |
| 599 | SNGX | Soligenix, Inc. | 4.83M | 7.96% | 268,391 | 2.34K |
| 600 | CNSP | CNS Pharmaceuticals, Inc. | 4.82M | 5.50% | 124,607 | - |
| 601 | MTNB | Matinas BioPharma Holdings, Inc. | 4.73M | -1.27% | 52,034 | - |
| 602 | ATNF | 180 Life Sciences Corp. | 4.69M | -5.02% | 18,900 | - |
| 603 | GLTO | Galecto, Inc. | 4.67M | 0.86% | 8,613 | - |
| 604 | SILO | Silo Pharma, Inc. | 4.63M | 1.68% | 90,865 | 72.10K |
| 605 | AZTR | Azitra, Inc. | 4.52M | 0.15% | 557,699 | 7.50K |
| 606 | MBIO | Mustang Bio, Inc. | 4.49M | -0.49% | 157,303 | - |
| 607 | MBRX | Moleculin Biotech, Inc. | 4.45M | -2.17% | 3,552,685 | - |
| 608 | CMND | Clearmind Medicine Inc. | 4.38M | -3.35% | 37,619 | - |
| 609 | GLMD | Galmed Pharmaceuticals Ltd. | 4.08M | 0.85% | 83,965 | - |
| 610 | PLRZ | Polyrizon Ltd. | 3.93M | 4.75% | 372,017 | - |
| 611 | DRMA | Dermata Therapeutics, Inc. | 3.83M | 2.42% | 65,888 | - |
| 612 | ARTL | Artelo Biosciences, Inc. | 3.79M | 0.89% | 12,692 | - |
| 613 | CERO | CERo Therapeutics Holdings, Inc. | 3.78M | -8.43% | 164,708 | - |
| 614 | VIVS | VivoSim Labs, Inc. | 3.77M | 2.11% | 9,403 | 144.00K |
| 615 | ENSC | Ensysce Biosciences, Inc. | 3.73M | 2.25% | 29,411 | 6.22M |
| 616 | TOVX | Theriva Biologics, Inc. | 3.64M | 1.02% | 98,459 | - |
| 617 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 3.57M | -1.86% | 25,085 | 1.00M |
| 618 | NBY | NovaBay Pharmaceuticals, Inc. | 3.50M | 0.33% | 19,935 | 9.78M |
| 619 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.45M | -3.89% | 6,084 | 802.32K |
| 620 | PALI | Palisade Bio, Inc. | 3.39M | -1.04% | 106,285 | - |
| 621 | SPRC | SciSparc Ltd. | 3.39M | -1.34% | 171,211 | 1.31M |
| 622 | VRAX | Virax Biolabs Group Limited | 3.39M | 1.30% | 24,240 | 84.87K |
| 623 | ZVSA | ZyVersa Therapeutics, Inc. | 3.32M | 2.31% | 371,428 | - |
| 624 | JAGX | Jaguar Health, Inc. | 3.31M | -7.75% | 73,649 | 11.55M |
| 625 | ENVB | Enveric Biosciences, Inc. | 3.19M | 1.57% | 34,702 | - |
| 626 | XRTX | XORTX Therapeutics Inc. | 3.08M | 11.90% | 63,325 | - |
| 627 | GRI | GRI Bio, Inc. | 2.96M | -1.56% | 49,765 | - |
| 628 | ADTX | Aditxt, Inc. | 2.95M | -10.90% | 507,499 | 55.32K |
| 629 | ELAB | PMGC Holdings Inc. | 2.94M | -1.38% | 30,007 | 2.45M |
| 630 | QLGN | Qualigen Therapeutics, Inc. | 2.65M | 1.69% | 1,045 | - |
| 631 | CDT | Conduit Pharmaceuticals Inc. | 2.62M | 9.56% | 1,221,296 | - |
| 632 | BDRX | Biodexa Pharmaceuticals Plc | 2.59M | -3.50% | 153,387 | 104.90K |
| 633 | ONCO | Onconetix, Inc. | 2.50M | 3.23% | 161,951 | 1.93M |
| 634 | OGEN | Oragenics, Inc. | 2.46M | -1.72% | 43,307 | - |
| 635 | PTIX | Protagenic Therapeutics, Inc. | 2.13M | -6.46% | 122,458 | - |
| 636 | SLRX | Salarius Pharmaceuticals, Inc. | 2.11M | - | 133,948 | - |
| 637 | SCNI | Scinai Immunotherapeutics Ltd. | 2.10M | -8.91% | 30,995 | 658.00K |
| 638 | ALZN | Alzamend Neuro, Inc. | 2.09M | -2.40% | 106,326 | - |
| 639 | LIXT | Lixte Biotechnology Holdings, Inc. | 1.88M | -9.08% | 19,164 | - |
| 640 | ENTO | Entero Therapeutics, Inc. | 1.84M | -11.29% | 332,907 | - |
| 641 | TNFA | TNF Pharmaceuticals, Inc. | 1.79M | 0.40% | 4,224,443 | - |
| 642 | REVB | Revelation Biosciences, Inc. | 1.59M | -4.21% | 274,734 | - |
| 643 | WINT | Windtree Therapeutics, Inc. | 1.57M | -5.68% | 965,794 | - |
| 644 | NCNA | NuCana plc | 526.96K | 5.33% | 40,807,694 | - |